Abstract | OBJECTIVE: The aim of this study was to assess the use of 5-fluorouracil (5-FU), leucovorin and oxaliplatin (FOLFOX) regimens in clinical practice according to their efficacy and toxicity. METHODS: RESULTS: The median age of the patients was 56 years (range 17-78). Of the total 667 patients, 326 were given FOLFOX-4, 232 were given modified FOLFOX-4 and 109 were given FOLFOX-6. The distribution according to disease stage was 33 patients with stage IIIA colorectal cancer, 382 patients with stage IIIB and 252 patients with stage IIIC. The most common adverse events were neutropenia (54%), nausea (36.9%), neuropathy (38.2%) and anemia (33.1%) for all grades. The median follow-up time was 23 months (range 1-79). Three-year disease-free survival and overall survival were 65 and 85.7%, respectively. CONCLUSION:
|
Authors | Doğan Uncu, Sercan Aksoy, Bülent Çetin, Tarkan Yetişyiğit, Nuriye Özdemir, Veli Berk, Faysal Dane, Ali Inal, Hakan Harputluoğlu, Burçin Budakoğlu, Doğan Koca, Alper Sevinç, Sener Cihan, Ayşe Gök Durnalı, Metin Özkan, Mehmet Akif Öztürk, Abdurrahman Işıkdoğan, Süleyman Büyükberber, Mustafa Benekli, Tuğba Köş, Necati Alkış, Halit Karaca, Nazım Serdal Turhal, Nurullah Zengin, Anatolian Society of Medical Oncology |
Journal | Oncology
(Oncology)
Vol. 84
Issue 4
Pg. 240-5
( 2013)
ISSN: 1423-0232 [Electronic] Switzerland |
PMID | 23392240
(Publication Type: Clinical Trial, Journal Article, Multicenter Study)
|
Copyright | Copyright © 2012 S. Karger AG, Basel. |
Chemical References |
- Organoplatinum Compounds
- Leucovorin
- Fluorouracil
|
Topics |
- Adolescent
- Adult
- Aged
- Anemia
(chemically induced)
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Chemoradiotherapy
- Colorectal Neoplasms
(drug therapy, mortality, pathology, surgery)
- Disease-Free Survival
- Female
- Fluorouracil
(adverse effects, therapeutic use)
- Follow-Up Studies
- Humans
- Leucovorin
(adverse effects, therapeutic use)
- Male
- Middle Aged
- Nausea
(chemically induced)
- Neutropenia
(chemically induced)
- Organoplatinum Compounds
(adverse effects, therapeutic use)
- Retrospective Studies
- Treatment Outcome
- Young Adult
|